Shkreli's Turing Pharmaceuticals raised the price of an anti-parasitic drug from $13.50 to over $750 overnight, sparking ...

Tyr Pharma (ATYR) shares remain in focus on Thursday after controversial American investor Martin Shkreli revealed a short ...

Martin Shkreli, known for once hiking the price of a life-saving drug more than 4,000%, cannot return to the pharmaceutical industry after a federal appeals court on Tuesday upheld his lifetime ban.

A federal judge on Friday banned the controversial former pharmaceutical executive Martin Shkreli from ever working in that industry again and ordered him to return $64.6 million in wrongfully ...

Convicted “Pharma Bro” Martin Shkreli has finally been ousted as boss of the pharmaceutical company he founded, The Post has learned. Activist shareholders booted the group of directors still ...

Martin Shkreli, famous for jacking up the price of a generic drug, is touting a weird deal he says he made with Barron Trump. But his reputation for fraud precedes him.

Martin Shkreli’s Ex-Mentor Testifies About His Bad Behavior Steven Richardson, who as chairman of Retrophin fired him as chief executive, was a witness in Mr. Shkreli’s Brooklyn trial on ...

Martin Shkreli, the former pharmaceutical executive known for raising the price of a lifesaving drug more than 40-fold, has been released from prison, where he had been serving a seven-year term ...

Anna Delvey did know former hedge fund manager Martin Shkreli. At the time, Shkreli, known as "Pharma Bro," was the CEO of Turing Pharmaceuticals (now Vyera Pharmaceuticals).

Shkreli's father was also present for the reading of the verdict. Former drug company executive Martin Shkreli exits the U.S. District Court in Brooklyn, New York, July 28, 2017.

Martin Shkreli’s journey from pharma exec to inmate No. 87850-053 » Less than a year later, the U.S. indicted him, accusing Shkreli of running his funds like Ponzi schemes.

Martin Shkreli under investigation for allegedly using a cellphone to run company from prison March 8, 2019 More than 6 years ago Summary ...